Catherine Doherty reports 27,598 DGX share dispositions in Form 144 (NYSE: DGX)

Rhea-AI Filing Summary

Catherine T. Doherty reported sales of Common Stock under a Form 144 filing. The filing lists sales of $5,393,815.32 for 26,165 shares on 02/13/2026 and $293,521.39 for 1,433 shares on 02/19/2026.

The filing also shows 632 shares tied to restricted stock vesting dated 02/23/2026, identified as securities to be sold. The transactions are reported on a Form 144 related to Common shares.

Insights

Corporate Governance Analyst

Form 144 documents disclosed insider dispositions totaling 27,598 shares across February 2026.

Reported transactions include 26,165 shares sold on 02/13/2026 for $5,393,815.32 and 1,433 shares sold on 02/19/2026 for $293,521.39. The filing also lists 632 shares from restricted stock vesting dated 02/23/2026.

These entries are administrative disclosures of insider sales; cash‑flow treatment and buyer identities are not provided. Subsequent filings or broker confirmations would show execution details and whether planned 632‑share disposition occurred.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	632	131285.36	109866320	03/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2026	Restricted Stock Vesting	Issuer			632	02/23/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Catherine T. Doherty 500 Plaza Drive Secaucus NJ 07094	Common	02/13/2026	26165	5393815.32
Catherine T. Doherty 500 Plaza Drive Secaucus NJ 07094	Common	02/19/2026	1433	293521.39

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Catherine T. Doherty report in the Form 144 for DGX?

She reported dispositions of 26,165 shares on 02/13/2026 for $5,393,815.32 and 1,433 shares on 02/19/2026 for $293,521.39. The filing also lists 632 shares from restricted stock vesting on 02/23/2026.

Does the Form 144 show shares to be sold from restricted stock for DGX?

Yes. The filing lists 632 shares associated with restricted stock vesting dated 02/23/2026 under the "Securities To Be Sold" section. The entry identifies the shares as related to compensation vesting.

How many total shares are disclosed across the reported transactions?

The filing lists a total of 27,598 shares across reported items: 26,165 shares (02/13/2026), 1,433 shares (02/19/2026), and 632 shares tied to vesting (02/23/2026). The totals are the sum of listed rows.

Are sale proceeds disclosed in the Form 144 for these DGX trades?

Yes. The filing shows proceeds of $5,393,815.32 for the 26,165‑share sale on 02/13/2026 and $293,521.39 for the 1,433‑share sale on 02/19/2026. No proceeds are shown for the 632‑share vesting entry.

Who is the broker or intermediary listed on the Form 144?

The filing references Fidelity Brokerage Services LLC with an address at 900 Salem Street, Smithfield, RI and a date of 03/03/2026. The entry appears in the securities/broker details section of the form.